221800 — U2Bio Co Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for U2Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	106	-559	9,236	13,160	646
Depreciation
Amortisation
Non-Cash Items	-593	2,303	2,872	2,914	-3,443
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-757	-976	72.8	7,444	-676
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-767	1,374	12,751	24,406	-2,555
Capital Expenditures	-702	-347	-387	-1,142	-978
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-1,532	1,411	-116	-35,544	34,183
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities	-2,234	1,064	-503	-36,686	33,205
Financing Cash Flow Items	—	—	—	—	-326
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	4,509	-274	-265	-2,771	3,207
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	1,508	2,164	11,983	-15,052	33,858